Molecule developed by Bulgarian company may lead to Covid-19 medicine

The Bulgarian company, which announced a month ago that it had developed a molecule to fight coronavirus, has developed two more molecules to fight the infection. However, scientists are still looking for funding so that the molecules can pass all the tests before becoming a medicine.

An American company is already on track to come up with the right funds and buy the idea.

Finding the right molecule to attack all types of coronavirus without side effects is like finding the right key among thousands. Now a number of countries are looking to the Bulgarian company because they believe the key is in it.

Kristina Eskenazi, representative of the Bulgarian company that develops the molecule: Investors from different countries have started to contact us. We are currently in very advanced negotiations with US investors.

Americans insist on buying the Bulgarian molecules because tests in world laboratories have shown promising results.

In order to become a medicine, the molecule has a long way to go and more funds are needed for research. It takes BGN 8 million that the US is ready to provide.

Kristina Eskenazi, representative of the Bulgarian company that develops the molecule: Such medicine could possibly reach the end user in 8-9 months.

That is the good news. If the US provides the funding, they will have the patent. We will only know that the molecule was developed by Bulgarian scientists.

Kristina Eskenazi, Representative of the Bulgarian company: In practice, this will remain an asset of another country, of another company. It would be the one to make decisions how it will be produced, in what quantities, at which markets it would be sold. We want very much this molecule to be realized in Bulgaria.

The Ministry of Economy is ready to help through one of their agencies.

Boyko Takov, Executive Director of the Agency for Promotion of Small and Medium-Sized Enterprises: We will help them with whatever we can.

However, the possibilities are not huge. The only one so far is for the company to apply for a project under a programme. If it wins, it will only win 1/16th of the amount.

Boyko Takov, Executive Director of the Agency for Promotion of Small and Medium-Sized Enterprises: The amounts are up to BGN 500,000.

And it is not known how long the procedure will take.

Kristina Eskenazi, representative of the Bulgarian company: We cannot hold this molecule endlessly with us, as we see what is happening on an international scale and we cannot be indifferent.

Negotiations with America are already under way.

Kristina Eskenazi, representative of the Bulgarian company: It's literally a matter of weeks.

In a good scenario, the world will have a cure. Better yet, it will be Bulgarian.

Чуйте последните новини, където и да сте!
Последвайте ни във Facebook и Instagram
Следете и канала на БНТ в YouTube
Вече може да ни гледате и в TikTok
Намерете ни в Google News